Figure 3.
Correlations of the ALPS index and PSMD with cognitive function, FBG levels, and disease duration. (A) A negative correlation was observed between the ALPS index and FBG levels. (B) A negative correlation was observed between the ALPS index and disease duration. (C) A negative correlation was observed between PSMD and MoCA. (D) A positive correlation was observed between PSMD and disease duration. ALPS, analysis along the perivascular space; FBG, fasting blood glucose; MoCA, Montreal cognitive assessment; PSMD, peak width of skeletonized mean diffusivity.
